• CDMO Great Bay Bio Founded contractpharma
    June 19, 2019
    To build platform for CMC technology and pre-clinical R&D; names Michael Chan as CEO.
  • China puts focus on tackling biomedical problems biospectrumasia
    April 29, 2019
    Collaborating with CMC and China National Center for Biotechnology Development (CNCBD), ICGEB decided to set up the world’s first ICGEB regional research center (ICGEB-RRC) at CMC.
  • Numab & Intarcia Enter License Agreement contractpharma
    March 07, 2019
    Intarcia Therapeutics Inc. has executed its option to in-license ND016, being developed for the treatment of autoimmune disorders
  • WuXi STA, Ark Biosciences sign CMC development agreement biospectrumasia
    March 06, 2019
    STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Ark Biosciences, a global biotech company focusing on innovative drug discovery and development, especially in the area of viral infection and respiratory disease, have announced
  • DIA – CMC Workshop pharmafile
    May 15, 2018
    This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena.
  • Just China secures closing of Series B financing biospectrumasia
    August 11, 2017
    Globally, Just China has already established clinical development and CMC capabilities with a strong pipeline consisting of both bionovel and biosimilar products.
  • CMC Expands to Offer cGMP Processing contractpharma
    March 30, 2017
    Custom Milling & Consulting (CMC) has constructed a brand new state-of-the-art class 100,000/ISO 8 cGMP clean room.
PharmaSources Customer Service